Phreesia Q4 2024 Earnings Report
Key Takeaways
Phreesia announced its Q4 Fiscal Year 2024 results, with total revenue reaching $95.0 million, a 24% increase year-over-year. The company facilitated over 150 million patient visits in fiscal 2024 and is focusing on continued growth and a return to profitability.
Total revenue was $95.0 million, up 24% year-over-year.
Average number of healthcare services clients (AHSCs) was 3,962, up 26% year-over-year.
Healthcare services revenue per AHSC was $17,456, down 1% year-over-year.
Net loss was $30.6 million, compared to $38.0 million in the same period in the prior year.
Phreesia
Phreesia
Phreesia Revenue by Segment
Forward Guidance
Phreesia is maintaining its revenue outlook for fiscal year 2025 at a range of $424 million to $434 million, implying year-over-year growth of 19% to 22%. The company is updating its Adjusted EBITDA outlook for fiscal year 2025 to a range of $12 million to $20 million from a previous range of $10 million to $20 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income